en     ru     jp
 
 
    LOGIN HERE!  
Add privatebanking.com as a search provider to your browser  
 
Advanced Search  
Private Banking & Wealth Management search tool 
     
  Search entity  
 
 
Home
      
North America
      
USA
      
New York
      
New York
      
Private Equity
      
New Leaf Venture Partners (NLV)
       
 
Back
 
   
Review Avg.
Reviews: 0
 
Contact Page
Additional information
Write Review
Browse Review

 
Additional information
 
New Leaf Venture Partners (NLV)
 
 
Overview: 

New Leaf Venture Partners was formed in 2005, when the healthcare team spun out from the Sprout Group, the venture capital affiliate of Credit Suisse. The NLV team has been built over more than 15 years and has managed the health care technology portfolios in four Sprout funds as well as in two of its own NLV funds:

   New Leaf Ventures I, L.P., a $310 million fund that closed in 2005

   New Leaf Ventures II, L.P., a $450 million fund that closed in late 2007 and began its new investment cycle in 2008

The NLV team has invested more than $1.5 billion together in over 117 healthcare technology companies. The team’s investments have spanned a range of opportunities, including investments in start ups, private financings, PIPEs, structured financings, and small buyouts. Some representative investments include Array BioPharma (NASD: ARRY), Aspreva Pharmaceuticals (Galenica Group), Cephalon, Cerexa (Forest Laboratories), CombiChem (DuPont), Durata Therapeutics (NASD: DRTX), Epicor Medical (St. Jude), ePocrates, Ilypsa (Amgen), Intarcia Therapeutics, Intercept Pharmaceuticals (NASD: ICPT), Interlace Medical (Hologic), iRhythm Technologies, NxStage Medical, Nycomed (Takeda Pharmaceuticals), Oriel Therapeutics (Novartis-Sandoz Div.), Pathology Partners (Caris Ltd), Phase Forward (Oracle), Sapient Health Networks (WebMD), Synageva BioPharma (NASD: GEVA), Stromedix (Biogen Idec), and Visiogen (Abbott). The team also led recapitalizations of established companies such as Sirna Therapeutics (Merck) and ISTA Pharmaceuticals.

Both New Leaf Ventures I and New Leaf Ventures II are capitalized by commitments from highly respected limited partners, many of whom have invested with the New Leaf team over multiple funds. These limited partners include a mix of large corporate and public sector pension funds, funds of funds, endowments, and other private investors.
Asset Under Management:  $1.3 billion


 
 
Back
 
 

Privatebanking.com
Get the attention you always wanted and promote your corporate image and standing by benefiting from our state of the art interactive web presence.
    Privatebanking.com
   
  Read more  
 
Ascent Limited
Experience The Difference. Ascent Limited provides first class wealth management and family office services. Our private banking team, assembled from a group of highly experienced banking professionals, will provide financial advice tailored to your individual requirements and keep your portfolio in tune with the latest market developments and opportunities.
    Ascent Limited
   
  Read more  
 
 
Home News Library Newsletters Event Calendar Advertise About Contact FAQ
Privacy Policy     Terms of Service
 

©